Steffen Sammet to Magnetic Resonance Imaging
This is a "connection" page, showing publications Steffen Sammet has written about Magnetic Resonance Imaging.
Connection Strength
2.974
-
MR Imaging Artifacts in the Head and Neck Region: Pitfalls and Solutions. Neuroimaging Clin N Am. 2022 May; 32(2):279-286.
Score: 0.362
-
MRI-guided transurethral insonation of silica-shell phase-shift emulsions in the prostate with an advanced navigation platform. Med Phys. 2019 Feb; 46(2):774-788.
Score: 0.286
-
Comparison between whole-body and head and neck neurovascular coils for 3-T magnetic resonance proton resonance frequency shift thermography guidance in the head and neck region. Lasers Med Sci. 2018 Feb; 33(2):369-373.
Score: 0.267
-
Magnetic resonance safety. Abdom Radiol (NY). 2016 Mar; 41(3):444-51.
Score: 0.236
-
Implementation of a comprehensive MR safety course for medical students. J Magn Reson Imaging. 2015 Dec; 42(6):1478-86.
Score: 0.226
-
Residual magnetism in an MRI suite after field-rampdown: what are the issues and experiences? J Magn Reson Imaging. 2010 May; 31(5):1272-6.
Score: 0.158
-
[Proton spinlocking and T1 rho-weighted MR imaging at 1.5 T]. Z Med Phys. 2002; 12(1):16-23.
Score: 0.089
-
Assessment of Proton Resonance Frequency Shift Magnetic Resonance Thermography Imaging Quality for Head and Neck Tumors. Ear Nose Throat J. 2024 Mar; 103(3):NP135-NP138.
Score: 0.087
-
Association between white matter hyperintensities and stroke in a West African patient population: Evidence from the Stroke Investigative Research and Educational Network study. Neuroimage. 2020 07 15; 215:116789.
Score: 0.079
-
Musculoskeletal MRI Pulse Sequences: A Review for Residents and Fellows. Radiographics. 2019 Nov-Dec; 39(7):2038-2039.
Score: 0.076
-
Assessment of histotripsy-induced liquefaction with diagnostic ultrasound and magnetic resonance imaging in vitro and ex vivo. Phys Med Biol. 2019 05 02; 64(9):095023.
Score: 0.074
-
MRI compatibility of silver based wound dressings. Burns. 2018 12; 44(8):1940-1946.
Score: 0.069
-
Comparison of arterial input functions measured from ultra-fast dynamic contrast enhanced MRI and dynamic contrast enhanced computed tomography in prostate cancer patients. Phys Med Biol. 2018 01 30; 63(3):03NT01.
Score: 0.068
-
Contrast Extravasation versus Hemorrhage after Thrombectomy in Patients with Acute Stroke. J Neuroimaging. 2017 11; 27(6):570-576.
Score: 0.064
-
Validation of optimal DCE-MRI perfusion threshold to classify at-risk tumor imaging voxels in heterogeneous cervical cancer for outcome prediction. Magn Reson Imaging. 2014 Dec; 32(10):1198-205.
Score: 0.053
-
MR imaging of the prostate and adjacent anatomic structures before, during, and after ejaculation: qualitative and quantitative evaluation. Radiology. 2014 May; 271(2):452-60.
Score: 0.051
-
Prostate volumes derived from MRI and volume-adjusted serum prostate-specific antigen: correlation with Gleason score of prostate cancer. AJR Am J Roentgenol. 2013 Nov; 201(5):1041-8.
Score: 0.050
-
RF-related heating assessment of extracranial neurosurgical implants at 7T. Magn Reson Imaging. 2013 Jul; 31(6):1029-34.
Score: 0.049
-
Microcirculatory fraction (MCF(I)) as a potential imaging marker for tumor heterogeneity in breast cancer. Magn Reson Imaging. 2012 Oct; 30(8):1059-67.
Score: 0.046
-
Detecting cortical lesions in multiple sclerosis at 7 T using white matter signal attenuation. Magn Reson Imaging. 2012 Sep; 30(7):907-15.
Score: 0.045
-
Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):972-9.
Score: 0.044
-
Amide proton transfer MR imaging of prostate cancer: a preliminary study. J Magn Reson Imaging. 2011 Mar; 33(3):647-54.
Score: 0.042
-
Quantitative assessment of mobile protein levels in human knee synovial fluid: feasibility of chemical exchange saturation transfer (proteinCEST) MRI of osteoarthritis. Magn Reson Imaging. 2011 Apr; 29(3):335-41.
Score: 0.042
-
Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging. Invest Radiol. 2010 May; 45(5):233-44.
Score: 0.039
-
Postprocessing correction for distortions in T2* decay caused by quadratic cross-slice B0 inhomogeneity. Magn Reson Med. 2010 May; 63(5):1258-68.
Score: 0.039
-
Unsupervised learning of brain states from fMRI data. Med Image Comput Comput Assist Interv. 2010; 13(Pt 2):201-8.
Score: 0.039
-
Three-region MRI-based whole-body attenuation correction for automated PET reconstruction. Nucl Med Biol. 2010 Feb; 37(2):227-35.
Score: 0.038
-
Assessing the safety and compatibility of silver based wound dressings in a magnetic resonance environment. Burns. 2009 Dec; 35(8):1080-5.
Score: 0.037
-
Multispectral co-occurrence with three random variables in dynamic contrast enhanced magnetic resonance imaging of breast cancer. IEEE Trans Med Imaging. 2008 Oct; 27(10):1425-31.
Score: 0.035
-
Colorectal liver metastases: contrast agent diffusion coefficient for quantification of contrast enhancement heterogeneity at MR imaging. Radiology. 2008 Sep; 248(3):901-9.
Score: 0.035
-
Improving the pharmacokinetic parameter measurement in dynamic contrast-enhanced MRI by use of the arterial input function: theory and clinical application. Magn Reson Med. 2008 Jun; 59(6):1448-56.
Score: 0.035
-
Improvement in the reproducibility of region of interest using an auditory feedback loop: a pilot assessment using dynamic contrast-enhanced (DCE) breast MR images. J Magn Reson Imaging. 2008 Jan; 27(1):27-33.
Score: 0.034
-
Clinical magnetic resonance imaging of brain tumors at ultrahigh field: a state-of-the-art review. Top Magn Reson Imaging. 2006 Apr; 17(2):53-61.
Score: 0.030
-
AAPM Task Group 241: A medical physicist's guide to MRI-guided focused ultrasound body systems. Med Phys. 2021 Sep; 48(9):e772-e806.
Score: 0.021
-
MR Thermography-Guided Head and Neck Lesion Laser Ablation. AJNR Am J Neuroradiol. 2018 09; 39(9):1593-1596.
Score: 0.017
-
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer. J Clin Oncol. 2010 May 10; 28(14):2323-30.
Score: 0.010